Home
Conditions
Solid Tumor

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

716 public trials 251 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumor trial results

Completed

A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram

NCT00786838

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +20 more
Locations: Miami, Florida, United States

Charlotte, North Carolina, United States

Philadelphia, Pennsylvania, United States

Tacoma, Washington, United States

View all 17 locations

View Trial Details

Completed

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

NCT01364844

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +21 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

A Phase I Study of E7050 in Subjects With Solid Tumors

NCT01428141

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations: Nagoya, Aichi-ken, Japan

Kashiwa, Chiba, Japan

Sunto, Shizuoka, Japan

View Trial Details

Completed

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

NCT01170897

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations: Ramesh K. Ramanathan M.D. Scottsdale, Arizona, United States

Mayo Clinic - Scottsdale Scottsdale, Arizona, United States

cCare - California Cancer Associatesfor Research Excellence Encinitas, California, United States

Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation

NCT00894049

Conditions: Allogeneic Cell Transplantaion, Allograft, Hematologic Diseases, +6 more
Locations: CHU Bordeaux Pessac, France

CHU Clermont-Ferrand, France

CHU Lyon, France

Institut Paoli-Calmettes Marseille, France

View Trial Details

Completed

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

NCT00927966

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors

NCT00721669

Conditions: Solid Tumor
Locations: Florida Cancer Specialists Fort Myers, Florida, United States

University of Oklahoma Oklahoma City, Oklahoma, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

NCT01225536

Conditions: Solid Tumor
Locations: Los Angeles, California, United States

New Haven, Connecticut, United States

New Brunswick, New Jersey, United States

Rozzano, Italy

View Trial Details

Completed

Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors

NCT00834704

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations: T Gen Clinical Research Services Scottsdale, Arizona, United States

Premiere Oncology Santa Monica, California, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

STAT3 Inhibitor for Solid Tumors

NCT00955812

Conditions: Advanced Cancer, Solid Tumor
Locations: Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States

UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Solid Tumor

Solid Tumor trial results

Related conditions